The new edition of EvaluatePharma World Preview 2017, Outlook to 2022 takes an in-depth look at how drug sales are being impacted by more scrutiny around pricing.
Some key highlights in the report:
— Worldwide prescription drug sales forecasted to grow at a robust 6.5 percent (CAGR) through 2022 to reach $1.06 trillion; and
— 32 percent of the 2022 increase in sales to come from orphan drugs (about $95 billion)
